This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
£0.01011
Share price
-33.50%
Change (1 day)
-98.94%
Change (1 year)
Categories
Earnings for Athersys (ATHX)
Earnings in 2023 (TTM): -£33.83 Million
According to Athersys's latest financial reports the company's current earnings are £0.08 Million. In 2022 the company made an earning of -£57.67 Million, an increase over its 2021 earnings that were of -£65.19 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Athersys from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -£33.83 Million | -41.34% |
| 2022 | -£57.67 Million | -11.54% |
| 2021 | -£65.19 Million | 11.14% |
| 2020 | -£58.66 Million | 72.2% |
| 2019 | -£34.07 Million | 77.29% |
| 2018 | -£19.22 Million | -22.91% |
| 2017 | -£24.93 Million | 111.89% |
| 2016 | -£11.77 Million | -8.52% |
| 2015 | -£12.86 Million | -40.81% |
| 2014 | -£21.73 Million | 18.62% |
| 2013 | -£18.32 Million | |
| 2011 | -£10.32 Million | 19.71% |
| 2010 | -£8.62 Million | -26.28% |
| 2009 | -£11.7 Million | -18.21% |
| 2008 | -£14.3 Million | -8.28% |
| 2007 | -£15.59 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | £4.97 B | -16,023.57% | 🇺🇸 USA |
 Pfizer PFE | £7.74 B | -24,861.75% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £4.57 B | -14,725.74% | 🇺🇸 USA |
 Moderna
MRNA | -£2.54 Billion | 8,010.24% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £20.52 B | -65,729.04% | 🇺🇸 USA |
 United States Lime & Minerals USLM | £0.11 B | -461.74% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | -£0.47 Billion | 1,401.18% | 🇺🇸 USA |
 Merck MRK | £16.06 B | -51,462.48% | 🇺🇸 USA |
 Sanofi SNY | £6.56 B | -21,097.75% | 🇫🇷 France |